The present invention relates to a customizable
injectable solution comprising
Human Growth Hormone (HGH),
Insulin-like
Growth Factor 1 (IGF-1), or a
growth hormone secretagogue such as sermorelin or ipamorelin, combined with a blend of nutrients including amino acids, vitamins, electrolytes, functional
mushroom extracts, and optionally
mushroom mycelium. The solution is delivered via a dual-chamber
syringe to preserve component stability, with mixing occurring immediately before administration. The formulation is suitable for subcutaneous, intramuscular, or intravenous injection and may be tailored for
muscle growth, cognitive performance, immune support, or
neuroregeneration. The invention also contemplates injectable formulations of functional mushrooms alone, as well as alternative
delivery methods such as sublingual troches containing GH-inducing peptides, functional mushrooms, and
ketamine. This
system provides a versatile, bioavailable, and clinically adaptable approach to personalized health optimization.